Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 218,237,303 papers from all fields of science
Search
Sign In
Create Free Account
testis cancer, refractory
Known as:
Refractory Cancer of Testis
, testicular cancer, refractory
, refractory carcinoma of the testis
Expand
Malignant testicular germ cell tumor that is resistant to treatment.
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
14 relations
Aneuploidy
Cryptorchidism
Germ Cells
Germinal Layer
Expand
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2007
Highly Cited
2007
Adjunction of rituximab to steroids and immunosuppressants for refractory/relapsing Wegener's granulomatosis: a study on 8 patients.
B. Brihaye
,
A. Aouba
,
C. Pagnoux
,
P. Cohen
,
F. Lacassin
,
L. Guillevin
Clinical and Experimental Rheumatology
2007
Corpus ID: 25958425
OBJECTIVE Rituximab, an anti-CD20 biotherapy, has been effective against refractory and/or relapsing Wegener's granulomatosis (WG…
Expand
Highly Cited
2004
Highly Cited
2004
Experience of long-term synbiotic therapy in seven short bowel patients with refractory enterocolitis.
Y. Kanamori
,
M. Sugiyama
,
K. Hashizume
,
N. Yuki
,
M. Morotomi
,
R. Tanaka
Journal of Pediatric Surgery
2004
Corpus ID: 23336505
Highly Cited
2004
Highly Cited
2004
Comparative cytotoxicity of oxaliplatin and cisplatin in non-seminomatous germ cell cancer cell lines
T. Dunn
,
H. Schmoll
,
V. Grünwald
,
V. Bokemeyer
,
Jochen Casper
Investigational new drugs
2004
Corpus ID: 24607532
Approximately 70-80% of patients with metastatic testicular cancer will become disease free with cisplatin-based chemotherapy and…
Expand
2004
2004
High-dose intravenous azathioprine pulse treatment in refractory Wegener's granulomatosis.
P. Aries
,
B. Hellmich
,
E. Reinhold-Keller
,
W. Gross
Rheumatology
2004
Corpus ID: 34115305
In summary, we have shown that anti-BiP antibody levels arenot raised in JIA patients as a whole but remain specific for RAand…
Expand
Highly Cited
2003
Highly Cited
2003
Treatment of refractory myasthenia: “Rebooting” with high‐dose cyclophosphamide
D. Drachman
,
Richard J. Jones
,
R. Brodsky
Annals of Neurology
2003
Corpus ID: 9781757
Patients with myasthenia gravis (MG) who do not respond to conventional immunotherapeutic agents, or cannot tolerate their side…
Expand
Review
2000
Review
2000
The Expert Consensus Guideline Series: Medication Treatment of Bipolar Disorder 2000.
G. Sachs
,
D. Printz
,
D. Kahn
,
D. Carpenter
,
J. Docherty
Postgraduate medicine
2000
Corpus ID: 46548003
OBJECTIVES New treatments for bipolar disorder have been reported since we first published survey-based expert consensus…
Expand
Highly Cited
1999
Highly Cited
1999
Gemcitabine in patients with relapsed or cisplatin-refractory testicular cancer.
C. Bokemeyer
,
A. Gerl
,
+6 authors
L. Kanz
Journal of Clinical Oncology
1999
Corpus ID: 23632245
PURPOSE Despite generally high cure rates in patients with metastatic testicular germ cell tumors, patients with incomplete…
Expand
Highly Cited
1997
Highly Cited
1997
The use of tetracycline-containing controlled-release fibers in the treatment of refractory periodontitis.
B. Vandekerckhove
,
M. Quirynen
,
D. van Steenberghe
The Journal of Periodontology
1997
Corpus ID: 2707346
The purpose of this study was to evaluate the safety and clinical efficacy of controlled-release tetracycline-containing fibers…
Expand
Highly Cited
1996
Highly Cited
1996
Arthroscopic management of refractory shoulder stiffness.
D. T. Harryman
,
F A Matsen
,
J. Sidles
Arthroscopy: The Journal of Arthroscopy And…
1996
Corpus ID: 26617285
Highly Cited
1984
Highly Cited
1984
High-dose melphalan therapy for the treatment of children with refractory neuroblastoma and Ewing's sarcoma.
J. Graham-Pole
,
H. Lazarus
,
+4 authors
S. Strandjord
American Journal Of Pediatric Hematology/Oncology
1984
Corpus ID: 23546486
Neuroblastoma and Ewing's sarcoma are examples of pediatric cancers in which disseminated disease is often present at diagnosis…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE